ѻý

Third Dose a Charm in Israel? Door-to-Door 'Goons'; Cervids Catch COVID, Too!

<ѻý class="mpt-content-deck">— A daily roundup of news on COVID-19 and the rest of medicine
MedpageToday
COVID-19 UPDATE and Other News over a background of illustrated coronaviruses

Note that some links may require registration or subscription.

Israel approved a for citizens over 60 years of age. (Times of Israel)

Shortly after President Biden urged the Defense Department to make COVID-19 vaccines mandatory for military personnel, the Pentagon said . (The Hill)

As of Friday at 8 a.m. EDT, the in the U.S. included 34,754,758 cases and 612,129 deaths, increases of 79,399 and 324, respectively, compared to this time a day ago.

COVID-19-related in states where the fully vaccinated rate remains stuck below 50%. (CNN)

But "LOCK YOUR DOORS, KIDS," President Biden is "sending goons DOOR-TO-DOOR to make you take a COVID-19 vaccine," according to texts and . (Washington Post)

, two-thirds of the vaccine-eligible U.S. population (ages 12 and up) have received at least one shot, with 57.7% now fully vaccinated.

In Louisiana, a judge is in exchange for a COVID shot. (AP via KLFY)

of U.S. counties fall under the CDC's new masking recommendations for areas with substantial or high transmission. (Reuters)

Disney theme parks will follow the new guidance and , vaccinated or not. (ABC7)

, at least in the sense that they're susceptible to SARS-CoV-2 infection, according to serum samples from the Department of Agriculture's Animal and Plant Health Inspection Service.

All Americans can get they don't have health insurance. (NPR)

Globally, an ambitious plan to control HIV/AIDS -- whether it be new infections in children, adolescents, and young women; or getting HIV-positive kids onto medication. (NPR)

A lawsuit from the National Council of Negro Women alleges that Johnson & Johnson targeted Black women with . (FiercePharma)

In a phase III trial of moderate-to-severe chronic spontaneous urticaria, adding dupilumab (Dupixent) to standard of care significantly improved patients' symptoms of itch and hives, .

Wondering what's up at FDA? The agency allowed Emergent BioSolutions' troubled Baltimore-area plant . (CNN)

Meanwhile, another FDA approval for mepolizumab (Nucala), this time for adults with chronic rhinosinusitis and nasal polyps.

And AbbVie got a for onabotulinumtoxinA (Botox) for treating upper limb spasticity in eight more muscles.

approval of selexipag (Uptravi) for intravenous use in certain adults with pulmonary arterial hypertension who are temporarily unable to take oral therapy.

Lastly, the agency , slapping the sites with a strongly worded "untitled letter" concerning sellers hawking "potentially dangerous" weight loss and male enhancement products.

Okay, one more: AstraZeneca said for its COVID-19 vaccine later this year. (AP)

  • author['full_name']

    Ian Ingram is Managing Editor at ѻý and helps cover oncology for the site.